https://www.selleckchem.com/pr....oducts/phorbol-12-my
considered the drug to be of unclear benefit was 8% higher than that of the participants in the group with 2 sources of uncertainty (72/195, 36.9% vs 57/197, 28.9%, respectively). However, there was no significant difference compared to the version with 1 source of uncertainty (P=.31). We did not find any meaningful differences between the research summaries for the secondary outcomes. Communicating even a large magnitude of uncertainty for a treatment effect had little impact on the perceived effectiveness. Effo
Like
Comment
Share
